首页|舒脉胶囊干预大鼠髂动脉球囊损伤后的炎症作用机制

舒脉胶囊干预大鼠髂动脉球囊损伤后的炎症作用机制

扫码查看
目的 探讨舒脉胶囊抑制大鼠髂动脉球囊损伤后的炎症作用机制.方法 30只大鼠随机分为假手术组、模型组、舒脉胶囊低剂量组、舒脉胶囊中剂量组、舒脉胶囊高剂量组,每组各6只.模型组、舒脉胶囊低、中和高剂量组均采用经皮冠状动脉腔内血管成形术(percutaneous transluminal coronary angioplasty,PTCA)扩张导管,经大鼠左股动脉牵拉损伤大鼠左髂动脉建立下肢动脉再狭窄模型,假手术组不进行球囊损伤.术后第1天,假手术组和模型组给予0.9%氯化钠溶液灌胃,每300g大鼠体质量给予1ml 0.9%氯化钠溶液,1次/天,舒脉胶囊低、中和高剂量组分别给予0.0324、0.0648、0.1296g/ml舒脉胶囊0.9%氯化钠溶液灌胃.术后14天,弹力纤维染色观察各组大鼠左髂动脉内膜增生情况,测量并计算内膜面积、中膜面积及内膜中膜面积比;酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测血清白细胞介素-6(interleukin-6,IL-6)水平变化;免疫组化法检测检测血管壁IL-6及核因子-κB(nuclear factor-kappa B,NF-κB)表达;Western blot法检测大鼠左髂动脉血管组织中NF-κB蛋白表达.结果 与假手术组比较,模型组血管腔明显变窄(P<0.0001),模型组IL-6水平明显升高(P<0.0001),模型组NF-κB水平明显升高(P<0.001);与模型组比较,舒脉胶囊中、高剂量组NF-κB蛋白含量降低(P<0.05);与舒脉胶囊低剂量组比较,舒脉胶囊中、高剂量组IL-6水平降低(P<0.05).结论 舒脉胶囊可能通过干预NF-κB通路,抑制血管炎症,从而减轻介入术后血管内膜的增生.
Mechanism of Shumaijiaonang on the Inflammation of the Iliac Artery after Balloon Injury in Rats
Objective To investigate the mechanism of Shumaijiaonang in inhibiting the inflammation of iliac artery after balloon in-jury in rats.Methods Thirty rats were randomly divided into sham operation group,model group,Shumaijiaonang low-dose group,Shumaijiaonang medium-dose group and Shumaijiaonang high-dose group.Percutaneous transluminal coronary angioplasty(PTCA)was performed in the model group and in the Shumaijiaonang low,medium and high-dose groups.The lower limb artery restenosis model was established after the left iliac artery was damaged by the left femoral artery.There was no balloon injury in the sham operation group.On the first day after surgery,sham operation group and model group were given normal saline instillation,1ml of normal saline per 300g body weight of rats once a day,and Shumaijiaonang low-dose and Shumaijiaonang medium-dose groups were given 0.0324g/ml,0.0648g/ml and 0.1296g/ml Shumaijiaonang saline solution instillation,respectively.The hyperplasia of left iliac artery was observed 14days after operation with elastic fiber staining,and the intima area,media area and the ratio of the intima area were measured and calculated.En-zyme-linked immunosorbent assay(ELISA)was used to detect the change of serum interleukin-6(IL-6)level.The expression of IL-6 and NF-κB in vascular wall was detected by immunohistochemistry.The protein expression of NF-κB in left iliac artery was de-tected by Western blot.Results Compared with sham operation group,the vascular lumen in model group was significantly narrowed(P<0.0001),the level of IL-6 was significantly increased(P<0.0001),the level of NF-κB was significantly increased(P<0.001).Compared with model group,the content of NF-κB protein in Shumaijiaonang medium and high-dose groups was decreased(P<0.05).Compared with Shumaijiaonang low-dose group,the level of IL-6 in Shumaijiaonang medium and high-dose groups was decreased(P<0.05).Conclusion Shumaijiaonang may inhibit vascular inflammation by intervening NF-κB pathway,thus reducing the hyperplasia of vascular intima after interventionization.

Peripheral arterial diseaseBalloon injuryInflammationShumaijiaonangRats

郭卉、吕春燕、焦琳茜、谢书睿、徐旭英

展开 >

100010 首都医科大学附属北京中医医院

外周动脉疾病 球囊损伤 炎症 舒脉胶囊 大鼠

国家自然科学基金国家自然科学基金青年科学基金

8187311882004120

2024

医学研究杂志
中国医学科学院

医学研究杂志

CSTPCD
影响因子:0.702
ISSN:1673-548X
年,卷(期):2024.53(3)
  • 17